Two alumni of the Johns Hopkins Carey Business School’s Global MBA program were awarded a $100,000 Maryland Innovation Initiative award last July from TEDCO, the state’s Technology Development Corporation.
Sebastian Seiguer and Morad Elmi graduated from Carey in 2013 and lead emocha Mobile Health Inc., a Baltimore-based company that participated in the Johns Hopkins-backed Dreamit Health Baltimore accelerator program for start-ups held from January to May this year.
The emocha technology enables physicians and clinicians to track patient data through smartphone apps.
As Global MBA students, Seiguer and Elmi were teammates in the program’s Discovery to Market (D2M) experiential learning curriculum, which teaches students to assess the commercial potential of scientific discoveries and technological innovations.
“The goal of Discovery to Market is to produce future chief innovation officers and informed CEOs who truly understand the complex interplay of science, technology, and innovation to create revolutionary business models for companies around the world,” says Nayoung Louie, a lecturer on the Carey Business School faculty and a program coordinator for Discovery to Market. “We are thrilled to see the founding team of emocha emerge from the D2M experience with such great success in just one year following graduation from the Carey Business School.”
In D2M, Seiguer and Elmi worked with an international team of classmates to deliver a commercialization feasibility study to Johns Hopkins Wilmer Eye Institute researchers during the 2012-2013 academic year. The researchers, led by Wilmer research scientist Jordan Green, had formed a company called AsclepiX Therapeutics. The D2M team’s input and recommendations helped the company move forward with grants, development, and a licensing strategy, and last summer AsclepiX likewise was named a recipient of a $100,000 Maryland Innovation Initiative award.
The emocha technology was created by Johns Hopkins scientists in 2008, and Seiguer learned about it while working as an analyst in the university’s Technology Transfer office during his second year in the Global MBA program. “We licensed the core emocha technology from Johns Hopkins and the D2M experience provided us the perfect model and the framework to evaluate and then commercialize the opportunity,” explains Seiguer, CEO of emocha Mobile Health Inc. Elmi is the company’s director of marketing. They say the grant will be used to further develop the company.